FIGS Klasse A FIGS, Inc. Class A Common Stock
NYSE · Textiles, Apparel & Luxury Goods · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026FIGS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
FIGS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über FIGS, Inc. Class A Common Stock Unternehmensübersicht von Wikipedia
Figs (stylized as FIGS) is an American clothing company based in Santa Monica, California. The company sells scrubs and other products for healthcare professionals. It was founded in 2013 by Heather Hasson and Trina Spear, who are co-CEOs.
History
FIGS was founded by Heather Hasson and Trina Spear in Los Angeles, California in 2013. Hasson had the business idea when she realized that, unlike companies such as Lululemon, Under Armour, and Nike, that make clothes for athletes, there were no companies making fitted uniforms for health care professionals. Spear worked on Wall Street at the time and helped Hasson develop the business idea.
Hasson and Spear started FIGS using only their personal savings. They designed an alternative to the common scrubs available. Initially, they sold their product out of the parking lots of hospitals, getting feedback from staff. In 2013, Hasson and Spear raised a $2 million seed round so that they would not run out of product. In 2014 and 2015, they raised an additional $3 million. In 2016, the Lululemon-backed venture capital fund, Campfire, led the Series A funding round, which raised $5 million.
In 2017, Thomas Tull, businessman and founder of Legendary Pictures, invested $65 million in the company and became majority owner of FIGS. Others who have invested include Will Smith, Irving Place Capital, former Lululemon CEO Christine Day, and Mohr Davidow Ventures.
The company headquarters are in Santa Monica, California. In December 2015, FIGS was selected to join the Endeavor network, a startup accelerator and mentorship program. As of 2018 the company had raised a total of $75 million in funding. FIGS was recognized as one of the fastest-growing companies in the United States by Inc. in 2018, with the company having a three-year growth of 9,948%.
In 2019 FIGS opened a pop-up shop in Los Angeles. It added face masks to its products during the coronavirus pandemic in 2020, and expanded sales to Australia and the United Kingdom. In 2020, revenue doubled to $263 million and profits were almost $50 million.
In May 2021 FIGS filed for an initial public offering for $3 billion. On May 27, 2021, it became the first company led by two female cofounders to trade on the New York Stock Exchange. Also for the first time, FIGS allowed retail investors early access to purchase shares before the official sale began on the NYSE.
In November 2022, a California jury rejected all claims made by a competitor as "not valid" in a lawsuit alleging FIGS had "false advertising and misleading business practices." The lawsuit was concluded after almost 4 years of litigation.
By 2023, non-scrub products, including lab coats, activewear, loungewear, footwear, and compression socks, accounted for approximately 20% of the company's revenue.
Operation
FIGS sells scrubs, other medical clothing and associated products, including scrub tops, scrub pants, underscrubs, lab coats, activewear, and loungewear. The scrubs are made with a proprietary material that is antimicrobial for odor resistance with four-way stretch and pockets.
All sales are online, via the company's website. FIGS predicted revenue of over $250 million in 2020, mostly through the sale of its upgraded scrubs. The company's warehouse is in City of Industry, California.
Charitable operations
FIGS also operates the Threads for Threads program, which donates sets of scrubs to countries with limited access to medical apparel. The program includes giving trips and results in the donations of scrubs around the world. By 2019 the initiative had donated over 500,000 sets of scrubs in over 35 countries.
In the COVID-19 pandemic in early 2020, FIGS donated 30,000 sets of scrubs to New York hospitals Bellevue and Mount Sinai, and sent 100 care packages to health care workers every week. It contracted the production of over one million N95 masks and also donated them to hospitals and medical professionals.
Marketing
In October 2020, FIGS released a promotional video featuring a female osteopathic physician in neon pink scrubs reading a book titled "Medical Terminology for Dummies" while holding it upside down. The camera then cut to a zoomed in view of a blank badge labeled with the letters "DO". The video was taken down after widespread criticism as sexist, particularly from female physicians and osteopathic physicians.
Hasson and Spear apologized for the video and said they planned to hire consultants to help with future videos to avoid repeating this mistake. FIGS later partnered with the American Osteopathic Association and pledged $100,000 to it.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | FIGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 41.05-Jahres-Durchschnitt ≈5.8 | ≈5.8 | 18.9 | Überbewertet |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | FIGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 68.9%5-Jahres-Durchschnitt ≈69.0% | ≈69.0% | 61.2% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | 9.6%5-Jahres-Durchschnitt ≈4.6% | ≈4.6% | 6.9% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 11.1%5-Jahres-Durchschnitt ≈5.3% | ≈5.3% | 8.0% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 10.8%5-Jahres-Durchschnitt ≈5.5% | ≈5.5% | 7.7% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 8.7%5-Jahres-Durchschnitt ≈2.4% | ≈2.4% | 5.8% | Spitzenklasse | |
| ROA (TTM) | 11.3%5-Jahres-Durchschnitt ≈2.8% | ≈2.8% | 3.6% | Spitzenklasse | |
| ROE (TTM) | 14.8%5-Jahres-Durchschnitt ≈3.6% | ≈3.6% | 9.3% | Im Einklang | |
| ROIC | 6.3%5-Jahres-Durchschnitt ≈2.8% | ≈2.8% | 7.1% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | FIGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 5.05-Jahres-Durchschnitt ≈5.1 | ≈5.1 | 2.1 | Starke Liquidität | |
| Quick Ratio | 1.05-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 1.0 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | FIGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 13.6%5-Jahres-Durchschnitt ≈20.7% | ≈20.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 7.6%5-Jahres-Durchschnitt ≈15.0% | ≈15.0% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 19.1% | · | · | · | |
| EPS YoY (EPS VjV) | 850.0%5-Jahres-Durchschnitt ≈258.6% | ≈258.6% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 1159.2%5-Jahres-Durchschnitt ≈359.4% | ≈359.4% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 20.0% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -8.7% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 17.4% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -7.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | FIGS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.25-Jahres-Durchschnitt ≈1.4 | ≈1.4 | 1.2 | Im Einklang | |
| Inventory Turnover (Lagerumschlag) | 1.75-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 2.5 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 105.35-Jahres-Durchschnitt ≈100.8 | ≈100.8 | 9.0 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.9M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $0.11 | $0.07 | 59.7% |
| 31. März 2026 | $0.03 | $0.02 | 96.1% | |
| 31. Dezember 2025 | $0.10 | $0.02 | 373.9% | |
| 30. September 2025 | $0.05 | $0.02 | 170.3% | |
| 30. Juni 2025 | $0.04 | $0.02 | 106.2% | |
| 31. März 2025 | $0.00 | $-0.00 | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $631M | $556M | $546M | $506M | $420M | $263M | $110M | |
| Cost of Revenue | $211M | $180M | $169M | $151M | $118M | $73M | $31M | |
| Gross Profit | $420M | $376M | $377M | $354M | $301M | $190M | $79M | |
| SG&A Expense | $143M | $143M | $141M | $121M | $150M | $42M | $22M | |
| Operating Expenses | $382M | $373M | $343M | $317M | $290M | $132M | $80M | |
| Operating Income | $38M | $2M | $34M | $38M | $11M | $58M | $-347.0K | |
| Other Non-op | $312.0K | $833.0K | $-13.0K | $-647.0K | $-885.0K | $0 | · | |
| Pretax Income | $47M | $14M | $41M | $39M | $10M | $58M | $112.0K | |
| Income Tax | $13M | $12M | $18M | $18M | $19M | $8M | $0 | |
| Net Income | $34M | $3M | $23M | $21M | $-10M | $50M | $112.0K | |
| EPS (Basic) | $0.21 | $0.02 | $0.13 | $0.13 | $-0.06 | $0.32 | $0.00 | |
| EPS (Diluted) | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 | $0.30 | $0.00 | |
| Shares (Basic) | 163,462,072 | 169,201,983 | 168,065,721 | 165,268,185 | 159,177,713 | 153,327,308 | 153,052,983 | |
| Shares (Diluted) | 179,486,886 | 180,102,840 | 182,412,965 | 187,547,474 | 159,177,713 | 163,331,348 | 153,624,013 | |
| EBITDA | $47M | $9M | $37M | $40M | $12M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $82M | $86M | $144M | $160M | $195M | $58M | · | |
| Receivables | $5M | $7M | $7M | $6M | $2M | $6M | · | |
| Inventory | $128M | $116M | $119M | $178M | $86M | $50M | · | |
| Prepaid Expense | $12M | $13M | $12M | $12M | $7M | $7M | · | |
| Current Assets | $447M | $383M | $386M | $356M | $293M | $120M | · | |
| PP&E (Net) | $34M | $35M | $25M | $11M | $8M | $7M | · | |
| PP&E (Gross) | $56M | $48M | $33M | $16M | $10M | $8M | · | |
| Accum. Depreciation | $22M | $13M | $8M | $5M | $3M | $1M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $1M | $560.0K | $506.0K | · | |
| Total Assets | $580M | $510M | $473M | $395M | $312M | $134M | · | |
| Accounts Payable | $18M | $9M | $15M | $21M | $15M | $12M | · | |
| Accrued Liabilities | $21M | $42M | $8M | $26M | $25M | $7M | · | |
| Current Liabilities | $91M | $90M | $57M | $71M | $62M | $33M | · | |
| Capital Leases | $52M | $42M | $39M | $16M | $0 | · | · | |
| Other Non-current Liabilities | $182.0K | $83.0K | $183.0K | $176.0K | $243.0K | $0 | · | |
| Total Liabilities | $143M | $133M | $96M | $87M | $66M | $36M | · | |
| Common Stock | · | · | · | · | · | $15.0K | · | |
| Retained Earnings | $99M | $64M | $62M | $39M | $18M | $27M | · | |
| AOCI | $196.0K | $21.0K | $5.0K | $0 | · | · | · | |
| Stockholders' Equity | $437M | $377M | $377M | $308M | $246M | $98M | $39M | |
| Liabilities + Equity | $580M | $510M | $473M | $395M | $312M | $134M | · | |
| Shares Outstanding | · | · | · | · | 0 | 154,444,851 | · |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $3M | $2M | $1M | $946.0K | $500.0K | |
| Stock-based Comp | $27M | $43M | $46M | $37M | $81M | $9M | $179.0K | |
| Deferred Tax | $-544.0K | $7M | $-7M | $-732.0K | $-4M | $-7M | $0 | |
| Other Non-cash | $-8M | $22M | $37M | $-95M | $-3M | · | · | |
| Operating Cash Flow | $61M | $81M | $101M | $-35M | $66M | $22M | $7M | |
| CapEx | $8M | $17M | $16M | $5M | $3M | $2M | $5M | |
| Investing Cash Flow | $-64M | $-95M | $-117M | $-6M | $-3M | $-2M | $-5M | |
| Stock Issued | $0 | $250.0K | $0 | $0 | · | · | · | |
| Stock Repurchased | $3M | $45M | $0 | $0 | · | · | · | |
| Net Stock Activity | $-3M | $-45M | · | · | · | · | · | |
| Financing Cash Flow | $-969.0K | $-45M | $670.0K | $4M | $76M | $294.0K | $14M | |
| Net Change in Cash | $-4M | $-59M | $-16M | $-38M | $139M | $20M | $16M | |
| Taxes Paid | $8M | $13M | $21M | $12M | $15M | $18M | $0 | |
| Free Cash Flow | $53M | $64M | $85M | $-41M | $64M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.5% | 67.6% | 69.1% | 70.1% | 71.8% | · | · | |
| Operating Margin | 6.0% | 0.41% | 6.2% | 7.4% | 2.6% | · | · | |
| Net Margin | 5.4% | 0.49% | 4.2% | 4.2% | -2.3% | · | · | |
| Pretax Margin | 7.5% | 2.6% | 7.5% | 7.7% | 2.4% | · | · | |
| EBITDA Margin | 7.5% | 1.6% | 6.8% | 7.8% | 2.9% | · | · | |
| ROA | 6.3% | 0.55% | 5.2% | 6.0% | -4.3% | · | · | |
| ROE | 8.2% | 0.70% | 6.2% | 7.1% | -4.1% | · | · | |
| ROIC | 6.3% | 0.11% | 5.0% | 6.7% | -4.3% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 4.2 | 6.7 | 5.0 | 4.7 | · | · | |
| Quick Ratio | 1.0 | 1.0 | 2.6 | 2.3 | 3.2 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.1 | 1.3 | 1.4 | 1.9 | · | · | |
| Inventory Turnover | 1.7 | 1.5 | 1.1 | 1.1 | 1.7 | · | · | |
| Receivables Turnover | 105.3 | 84.3 | 85.0 | 127.4 | 102.1 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $3.52 | $3.08 | $2.99 | $2.70 | $2.64 | · | · | |
| Cash Flow / Share | $0.34 | $0.45 | $0.55 | $-0.19 | $0.42 | · | · | |
| EPS (TTM) | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 1.8% | 7.9% | 20.5% | 59.5% | · | · | |
| Revenue CAGR 3Y | 7.6% | 9.8% | 27.5% | · | · | · | · | |
| Revenue CAGR 5Y | 19.1% | · | · | · | · | · | · | |
| EPS YoY | 850.0% | -83.3% | 9.1% | · | · | · | · | |
| EPS CAGR 3Y | 20.0% | · | -26.3% | · | · | · | · | |
| EPS CAGR 5Y | -8.7% | · | · | · | · | · | · | |
| Net Income YoY | 1159.2% | -88.0% | 6.9% | · | · | · | · | |
| Net Income CAGR 3Y | 17.4% | · | -23.1% | · | · | · | · | |
| Net Income CAGR 5Y | -7.2% | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $631M | $556M | $546M | $506M | $420M | · | · | |
| Net Income TTM | $34M | $3M | $23M | $21M | $-10M | · | · | |
| Market Cap | · | · | · | · | $0 | · | · | |
| P/E | 59.8 | 309.5 | 57.9 | 61.2 | -459.3 | · | · | |
| P/S | · | · | · | · | 0.0 | · | · | |
| P / Tangible Book | · | · | · | · | 0.0 | · | · | |
| P / Cash Flow | · | · | · | · | 0.0 | · | · | |
| P / FCF | · | · | · | · | 0.0 | · | · | |
| Earnings Yield | 1.7% | 0.32% | 1.7% | 1.6% | -0.22% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $197M | $160M | $202M | $152M | $153M | $125M | $152M | $140M | $144M | $119M | $145M | $142M | $138M | $120M | $145M | $129M | |
| Cost of Revenue | $49M | $52M | $75M | $46M | $50M | $40M | $50M | $46M | $47M | $37M | $47M | $45M | $42M | $35M | $46M | $38M | |
| Gross Profit | $148M | $108M | $127M | $106M | $102M | $84M | $102M | $94M | $97M | $82M | $98M | $97M | $96M | $86M | $99M | $91M | |
| SG&A Expense | $40M | $38M | $37M | $37M | $35M | $34M | $36M | $36M | $36M | $36M | $35M | $36M | $35M | $34M | $37M | $28M | |
| Operating Expenses | $113M | $104M | $108M | $96M | $92M | $85M | $93M | $103M | $96M | $82M | $84M | $87M | $89M | $82M | $96M | $80M | |
| Operating Income | $35M | $4M | $19M | $10M | $10M | $-211.0K | $9M | $-9M | $2M | $443.0K | $14M | $10M | $7M | $3M | $3M | $11M | |
| Other Non-op | $-526.0K | $-277.0K | $307.0K | $9.0K | $-3.0K | $-1.0K | $841.0K | $2.0K | $0 | $-10.0K | $-2.0K | $-6.0K | $-4.0K | $-1.0K | $-647.0K | $1.0K | |
| Pretax Income | $37M | $6M | $21M | $12M | $12M | $2M | $12M | $-6M | $4M | $3M | $17M | $12M | $8M | $4M | $4M | $12M | |
| Income Tax | $9M | $157.0K | $3M | $3M | $5M | $2M | $10M | $-4M | $3M | $2M | $7M | $6M | $4M | $2M | $247.0K | $8M | |
| Net Income | $28M | $6M | $19M | $9M | $7M | $-102.0K | $2M | $-2M | $1M | $1M | $10M | $6M | $5M | $2M | $3M | $4M | |
| EPS (Basic) | $0.17 | $0.04 | $0.12 | $0.05 | $0.04 | $0.00 | $0.01 | $-0.01 | $0.01 | $0.01 | $0.05 | $0.04 | $0.03 | $0.01 | $0.03 | $0.02 | |
| EPS (Diluted) | $0.15 | $0.03 | $0.10 | $0.05 | $0.04 | $0.00 | $0.01 | $-0.01 | $0.01 | $0.01 | $0.06 | $0.03 | $0.02 | $0.01 | $0.01 | $0.02 | |
| Shares (Basic) | 166,467,633 | 166,460,085 | · | 163,665,566 | 162,683,329 | 162,465,988 | · | 170,168,732 | 170,393,480 | 169,923,479 | · | 168,668,844 | 167,423,656 | 166,773,335 | · | 165,543,067 | |
| Shares (Diluted) | 195,139,642 | 196,090,295 | · | 180,875,933 | 172,929,960 | 162,465,988 | · | 170,168,732 | 179,688,524 | 180,701,844 | · | 181,429,745 | 183,332,560 | 182,853,746 | · | 186,991,769 | |
| EBITDA | $35M | $8M | · | $10M | $10M | $2M | · | $-9M | $2M | $1M | · | $10M | $7M | $4M | · | $11M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $109M | $74M | $82M | $46M | $51M | $90M | $86M | $124M | $132M | $155M | · | $183M | $147M | $156M | · | $156M | |
| Receivables | $7M | $4M | $5M | $11M | $8M | $5M | $7M | $9M | $12M | $5M | · | $6M | $6M | $3M | · | $3M | |
| Inventory | $120M | $139M | $128M | $151M | $136M | $132M | $116M | $123M | $119M | $130M | · | $143M | $168M | $180M | · | $168M | |
| Prepaid Expense | $14M | $11M | $12M | $13M | $10M | $10M | $13M | $19M | $17M | $11M | · | $13M | $10M | $10M | · | $14M | |
| Current Assets | $453M | $432M | $447M | $418M | $394M | $400M | $383M | $434M | $417M | $406M | · | $395M | $369M | $350M | · | $346M | |
| PP&E (Net) | $33M | $33M | $34M | $34M | $33M | $34M | $35M | $35M | $35M | $28M | · | $16M | $11M | $11M | · | $11M | |
| PP&E (Gross) | $61M | $58M | $56M | $53M | $50M | $49M | $48M | $46M | $45M | $37M | · | $23M | $18M | $17M | · | $15M | |
| Accum. Depreciation | $28M | $25M | $22M | $19M | $17M | $15M | $13M | $11M | $10M | $9M | · | $7M | $6M | $5M | · | $4M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $583M | $563M | $580M | $545M | $517M | $522M | $510M | $542M | $526M | $511M | · | $442M | $411M | $388M | · | $386M | |
| Accounts Payable | $9M | $8M | $18M | $5M | $19M | $11M | $9M | $27M | $20M | $22M | · | $15M | $12M | $9M | · | $21M | |
| Accrued Liabilities | $40M | $36M | $21M | $34M | $22M | $54M | $42M | $29M | $22M | $17M | · | $16M | $18M | $21M | · | $32M | |
| Current Liabilities | $91M | $80M | $91M | $87M | $78M | $101M | $90M | $95M | $77M | $72M | · | $70M | $57M | $53M | · | $76M | |
| Capital Leases | $49M | $52M | $52M | $45M | $42M | $40M | $42M | $44M | $48M | $49M | · | $16M | $17M | $15M | · | $17M | |
| Other Non-current Liabilities | $264.0K | $263.0K | $182.0K | $83.0K | $83.0K | $83.0K | $83.0K | $183.0K | $183.0K | $183.0K | · | $176.0K | $176.0K | $176.0K | · | $215.0K | |
| Total Liabilities | $140M | $133M | $143M | $131M | $121M | $141M | $133M | $139M | $124M | $121M | · | $87M | $74M | $68M | · | $93M | |
| Retained Earnings | $133M | $105M | $99M | $80M | $71M | $64M | $64M | $63M | $64M | $63M | · | $52M | $46M | $41M | · | $36M | |
| AOCI | $-240.0K | $-103.0K | $196.0K | $162.0K | $70.0K | $-24.0K | $21.0K | $221.0K | $-47.0K | $-26.0K | · | $-4.0K | $-8.0K | · | · | · | |
| Stockholders' Equity | $442M | $431M | $437M | $413M | $397M | $382M | $377M | $404M | $402M | $390M | $377M | $355M | $337M | $320M | $308M | $292M | |
| Liabilities + Equity | $583M | $563M | $580M | $545M | $517M | $522M | $510M | $542M | $526M | $511M | · | $442M | $411M | $388M | · | $386M |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $1M | $850.0K | $814.0K | $756.0K | $713.0K | $659.0K | $637.0K | $479.0K | |
| Stock-based Comp | $7M | $5M | $5M | $7M | $8M | $7M | $10M | $11M | $10M | $12M | $11M | $12M | $12M | $11M | $11M | $9M | |
| Deferred Tax | $6.0K | $6.0K | $911.0K | $-2M | $-893.0K | $995.0K | $6M | $-2M | $2M | $251.0K | $-5M | $-857.0K | $-544.0K | $-440.0K | $244.0K | $-661.0K | |
| Other Non-cash | · | $-18M | · | · | · | $-896.0K | · | · | · | $-3M | · | · | · | $-16M | · | · | |
| Operating Cash Flow | $47M | $-3M | $61M | $3M | $-12M | $9M | $30M | $23M | $17M | $12M | $20M | $54M | $29M | $-3M | $5M | $-13M | |
| CapEx | $3M | $2M | $3M | $3M | $1M | $1M | $3M | $4M | $9M | $496.0K | $7M | $8M | $841.0K | $772.0K | $1M | $3M | |
| Investing Cash Flow | $11M | $14M | $-26M | $-9M | $-27M | $-2M | $-31M | $-23M | $-40M | $-474.0K | $-59M | $-18M | $-39M | $-772.0K | $-1M | $-3M | |
| Stock Repurchased | $24M | $9M | $0 | $0 | $0 | $3M | $38M | $7M | $0 | $0 | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-9M | · | · | · | $-3M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-23M | $-18M | $401.0K | $1M | $185.0K | $-3M | $-38M | $-7M | $254.0K | $10.0K | $153.0K | $126.0K | $636.0K | $-245.0K | $733.0K | $1M | |
| Net Change in Cash | $34M | $-8M | $36M | $-4M | $-39M | $4M | $-38M | $-8M | $-24M | $11M | $-39M | $36M | $-9M | $-4M | $4M | $-15M | |
| Free Cash Flow | · | $-6M | · | · | · | $8M | · | · | · | $11M | · | · | · | $-4M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.2% | 67.7% | · | 69.9% | 67.0% | 67.6% | · | 67.1% | 67.4% | 68.8% | · | 68.4% | 69.5% | 71.3% | · | 70.6% | |
| Operating Margin | 17.9% | 2.8% | · | 6.3% | 6.5% | -0.17% | · | -6.2% | 1.1% | 0.37% | · | 7.0% | 4.8% | 2.7% | · | 8.7% | |
| Net Margin | 14.4% | 3.9% | · | 5.8% | 4.7% | -0.08% | · | -1.2% | 0.76% | 1.2% | · | 4.3% | 3.3% | 1.6% | · | 3.1% | |
| Pretax Margin | 18.8% | 4.0% | · | 7.9% | 7.9% | 1.5% | · | -4.1% | 3.0% | 2.8% | · | 8.3% | 5.9% | 3.6% | · | 9.2% | |
| EBITDA Margin | 17.9% | 4.9% | · | 6.3% | 6.5% | 1.4% | · | -6.2% | 1.1% | 1.1% | · | 7.0% | 4.8% | 3.3% | · | 8.7% | |
| ROA | 5.2% | 1.2% | · | 1.6% | 1.4% | -0.02% | · | -0.35% | 0.23% | 0.32% | · | 1.5% | 1.2% | 0.52% | · | 1.2% | |
| ROE | 6.8% | 1.6% | · | 2.1% | 1.8% | -0.03% | · | -0.45% | 0.30% | 0.40% | · | 1.9% | 1.5% | 0.65% | · | 1.6% | |
| ROIC | 6.1% | 1.0% | · | 1.7% | 1.5% | 0.00% | · | -0.64% | 0.10% | 0.05% | · | 1.5% | 1.1% | 0.45% | · | 1.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 5.4 | · | 4.8 | 5.0 | 4.0 | · | 4.6 | 5.4 | 5.6 | · | 5.6 | 6.5 | 6.6 | · | 4.5 | |
| Quick Ratio | 1.3 | 1.0 | · | 0.7 | 0.8 | 0.9 | · | 1.4 | 1.9 | 2.2 | · | 2.7 | 2.7 | 3.0 | · | 2.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.3 | · | 0.4 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 26.8 | 34.3 | · | 15.2 | 15.6 | 24.3 | · | 19.4 | 16.7 | 29.5 | · | 34.0 | 27.8 | 39.9 | · | 34.3 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $1.01 | $0.82 | · | $0.84 | $0.88 | $0.77 | · | $0.82 | $0.80 | $0.66 | · | $0.78 | $0.75 | $0.66 | · | $0.69 | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $0.06 | · | · | · | $0.06 | · | · | · | $-0.02 | · | · | |
| EPS (TTM) | $0.33 | $0.22 | · | $0.10 | $0.04 | $0.01 | · | $0.07 | $0.11 | $0.12 | · | $0.07 | $0.06 | $0.07 | · | $0.20 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $710M | $666M | · | $581M | $570M | $561M | · | $549M | $551M | $545M | · | $546M | $532M | $516M | · | $490M | |
| Net Income TTM | $62M | $41M | · | $18M | $7M | $1M | · | $11M | $19M | $22M | · | $16M | $14M | $14M | · | $30M | |
| P/E | 31.0 | 67.1 | · | 66.9 | 141.0 | 459.0 | · | 97.7 | 48.5 | 41.5 | · | 84.3 | 137.8 | 88.4 | · | 41.2 | |
| Earnings Yield | 3.2% | 1.5% | · | 1.5% | 0.71% | 0.22% | · | 1.0% | 2.1% | 2.4% | · | 1.2% | 0.73% | 1.1% | · | 2.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $631M | $556M | $546M | $506M | $420M |
| Bruttogewinnmarge % | 66.5% | 67.6% | 69.1% | 70.1% | 71.8% |
| Betriebsgewinnmarge % | 6.0% | 0.41% | 6.2% | 7.4% | 2.6% |
| Nettoergebnis | $34M | $3M | $23M | $21M | $-10M |
| Verwässerte EPS | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 4.9 | 4.2 | 6.7 | 5.0 | 4.7 |
| Quick Ratio | 1.0 | 1.0 | 2.6 | 2.3 | 3.2 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $53M | $64M | $85M | $-41M | $64M |
Institutionelle Eigentümer (13F) 261 Einreicher · $1.7B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 48 (-16 vs. Vorquartal) | 44 (+24 vs. Vorquartal) | 91 (+6 vs. Vorquartal) | 73 (+8 vs. Vorquartal) | +7.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BAMCO INC /NY/ | $613.385.163 | 59.959.449 | 35,59% | Aktien |
| VANGUARD GROUP INC | $109.164.158 | 9.609.521 | 6,33% | Aktien |
| BlackRock, Inc. | $87.395.229 | 8.543.033 | 5,07% | Aktien |
| Driehaus Capital Management LLC | $52.799.465 | 5.161.238 | 3,06% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $47.786.110 | 4.671.174 | 2,77% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $44.938.896 | 4.392.854 | 2,61% | Aktien |
| MARSHALL WACE, LLP | $44.354.193 | 4.335.698 | 2,57% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $38.250.727 | 3.739.074 | 2,22% | Aktien |
| GOLDMAN SACHS GROUP INC | $37.747.165 | 3.689.850 | 2,19% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $37.264.048 | 3.641.706 | 2,16% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $36.514.827 | 3.568.384 | 2,12% | Aktien |
| Divisadero Street Capital Management, LP | $32.644.196 | 3.191.026 | 1,89% | Aktien |
| STATE STREET CORP | $27.017.614 | 2.641.018 | 1,57% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $24.874.429 | 2.431.518 | 1,44% | Aktien |
| FULLER & THALER ASSET MANAGEMENT, INC. | $21.646.913 | 2.116.023 | 1,26% | Aktien |
| JANE STREET GROUP, LLC | $21.222.105 | 2.074.497 | 1,23% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $20.588.591 | 2.012.570 | 1,19% | Aktien |
| AMERIPRISE FINANCIAL INC | $19.667.133 | 1.922.496 | 1,14% | Aktien |
| Nuveen, LLC | $19.330.046 | 1.889.545 | 1,12% | Aktien |
| CITADEL ADVISORS LLC | $18.466.225 | 1.805.105 | 1,07% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $17.166.963 | 1.678.100 | 1,00% | Aktien |
| JENNISON ASSOCIATES LLC | $15.300.726 | 1.495.672 | 0,89% | Aktien |
| Woodline Partners LP | $14.577.873 | 1.425.012 | 0,85% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $12.303.908 | 1.202.728 | 0,71% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.951.167 | 1.168.247 | 0,69% | Aktien |
| MACKENZIE FINANCIAL CORP | $11.718.127 | 1.145.467 | 0,68% | Aktien |
| Black Creek Investment Management Inc. | $11.049.812 | 1.080.138 | 0,64% | Aktien |
| MORGAN STANLEY | $10.919.254 | 1.067.375 | 0,63% | Aktien |
| NORTHERN TRUST CORP | $10.630.587 | 1.039.158 | 0,62% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $10.428.431 | 1.019.397 | 0,61% | Aktien |
| JPMORGAN CHASE & CO | $10.119.531 | 909.482 | 0,59% | Aktien |
| Balyasny Asset Management L.P. | $9.858.150 | 963.651 | 0,57% | Aktien |
| Qube Research & Technologies Ltd | $9.400.899 | 918.954 | 0,55% | Aktien |
| FIRST TRUST ADVISORS LP | $7.709.859 | 753.652 | 0,45% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.272.507 | 710.900 | 0,42% | Kaufoption |
| Applied Fundamental Research, LLC | $7.132.837 | 697.247 | 0,41% | Aktien |
| FMR LLC | $6.806.788 | 665.375 | 0,39% | Aktien |
| TWO SIGMA ADVISERS, LP | $6.297.984 | 554.400 | 0,37% | Aktien |
| UBS Group AG | $6.263.532 | 612.271 | 0,36% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $5.980.192 | 584.574 | 0,35% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $5.862.680 | 573.087 | 0,34% | Aktien |
| Hillsdale Investment Management Inc. | $5.134.539 | 501.910 | 0,30% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $4.831.915 | 472.328 | 0,28% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $4.204.653 | 411.012 | 0,24% | Aktien |
| D. E. Shaw & Co., Inc. | $4.196.581 | 410.223 | 0,24% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.877.977 | 379.079 | 0,23% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $3.614.597 | 353.333 | 0,21% | Aktien |
| Malaga Cove Capital, LLC | $3.492.164 | 341.365 | 0,20% | Aktien |
| ALGERT GLOBAL LLC | $3.484.573 | 340.623 | 0,20% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $3.360.892 | 328.533 | 0,20% | Aktien |
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Hasson Heather L. ×3 Einreichungen | 12. Mai 2026 | 8,40% | Änderung | · | SEC |
| Spear Catherine Eva ×3 Einreichungen | 12. Mai 2026 | 15,00% | Änderung | · | SEC |
| BAMCO INC /NY/, Baron Capital Management, Inc, Ronald Baron, Baron Capital Group, Inc, Baron Growth Fund, Baron Focused Growth Fund ×7 Einreichungen | 3. März 2026 | 37,93% | Änderung | · | SEC |
| Thomas J. Tull ×5 Einreichungen | 21. Februar 2025 | 0,00% | Änderung | · | SEC |
| Catherine Spear ×8 Einreichungen | 28. August 2024 | · | Erste Einreichung | · | SEC |
| Heather Hasson ×8 Einreichungen | 28. August 2024 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 18 Insider · 5 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Catherine Eva Spear | Chief Executive Officer | 1. Juli 2026 F | 1.733.408 | 0 | 3 | $-1.894.115 |
| Sarah Oughtred | Chief Financial Officer | 5. August 2026 F | 1.088.165 | 0 | 6 | $-1.097.115 |
| Kevin Fosty | Former Interim CFO | 7. August 2024 S | 65.536 | 0 | 0 | $0 |
| Daniella Turenshine | Chief Financial Officer | 5. März 2024 S | 409.858 | 0 | 0 | $0 |
| Hasson Heather L. | Executive Chairman | 5. August 2026 F | 1.396.852 | 0 | 4 | $-10.252.337 |
| Hsiao Yueh Jao | Direktor | 3. Juni 2026 A | 97.719 | 0 | 0 | $0 |
| Kenneth Jian-Hong Lin | Direktor | 3. Juni 2026 A | 161.705 | 0 | 0 | $0 |
| John Martin Willhite | Direktor | 3. Juni 2026 A | 3.263.095 | 0 | 0 | $0 |
| Sheila Antrum | Direktor | 3. Juni 2026 A | 115.663 | 0 | 0 | $0 |
| Melanie Anya Whelan | Direktor | 3. Juni 2026 A | 55.683 | 0 | 0 | $0 |
| Mario Jesus Marte | Direktor | 3. Juni 2026 A | 86.046 | 0 | 0 | $0 |
| Jeffrey A Wilke | Direktor | 3. Juni 2026 A | 227.577 | 0 | 0 | $0 |
| Alan G Lafley | Direktor | 17. Dezember 2024 G | 141.165 | 0 | 0 | $0 |
| Michael J Soenen | Direktor | 7. Juni 2023 A | 52.652 | 0 | 0 | $0 |
| Christopher Peter Varelas | Direktor | 1. Juni 2021 P | 52.274 | 0 | 0 | $0 |
| BAMCO INC /NY/ | 10%-Eigentümer | 20. Februar 2025 C | 27.833.825 | 0 | 0 | $0 |
| Thomas J. Tull | 10%-Eigentümer | 11. Januar 2025 X | 6.675.631 | 0 | 0 | $0 |
| Tulco, LLC | 10%-Eigentümer | 21. März 2022 C | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 35 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| FYC · First Trust Exchange-Traded AlphaDE… | 0,28% | 343.129 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 234.929 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,08% | 893.638 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 15.299 SH | 1. Oktober 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,07% | 85.273 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 102.017 SH | 19. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 31.082 NS | 31. Juli 2026 | N-PORT |
| FDIS · FIDELITY COVINGTON TRUST | 0,06% | 88.497 NS | 31. Juli 2026 | N-PORT |
| VCR · VANGUARD WORLD FUND | 0,05% | 355.298 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 81.956 SH | 1. Oktober 2026 | Täglich |
| EBIT · Harbor ETF Trust | 0,04% | 471 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 2.429.839 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,04% | 521.429 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 26.052 SH | 11. September 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 22.416 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 45.466 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 547.697 SH | 19. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.821.842 SH | 19. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,02% | 1.148.655 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 5.743 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,01% | 1.997.017 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 390.844 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 17.756 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 11.938 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 8.908 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 59.278 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 36.685 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 223.355 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 34.315 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 23.946 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 88 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.758.703 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.241 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 3.675 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 35.184 SH | 11. September 2026 | Täglich |
FIGS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
12-Monats-Kursziel
8 Analysten · 2026-09-29Mittelwert-Ziel $18.62 +37,8%
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| FIGS | · | 59.8 | 13.6% | 5.4% | 8.2% | 66.5% |
| LEVI | $8.60B | 15.2 | 4.1% | 9.2% | 26.5% | 61.7% |
| VFC | $6.42B | 25.6 | 1.1% | 2.6% | 15.3% | · |
| PVH | · | 119.9 | 3.4% | 0.28% | 0.52% | 57.5% |
| KTB | $3.40B | 15.2 | 20.9% | 7.2% | 42.8% | · |
| COLM | · | 17.0 | 0.85% | 5.2% | 10.5% | 50.5% |
| UAA | · | -5.1 | -3.8% | -10.0% | -30.3% | 45.5% |
| GIII | · | 19.0 | -7.0% | 2.3% | 3.9% | 39.4% |
| CRI | $1.21B | 13.1 | 1.9% | 3.2% | 10.3% | 45.4% |
| MOV | · | 19.5 | 2.7% | 4.0% | 5.4% | 54.2% |
| FOSL | · | -2.6 | -12.3% | · | · | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.